InspireMD Inc (NSPR)
1.85
-0.12
(-6.33%)
USD |
NASDAQ |
Apr 24, 16:00
InspireMD Enterprise Value: 4.372M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 4.372M |
April 23, 2024 | 7.304M |
April 22, 2024 | 5.779M |
April 19, 2024 | 10.00M |
April 18, 2024 | 11.20M |
April 17, 2024 | 12.82M |
April 16, 2024 | 13.75M |
April 15, 2024 | 14.22M |
April 12, 2024 | 15.40M |
April 11, 2024 | 15.87M |
April 10, 2024 | 13.05M |
April 09, 2024 | 14.46M |
April 08, 2024 | 15.93M |
April 05, 2024 | 14.69M |
April 04, 2024 | 14.69M |
April 03, 2024 | 12.58M |
April 02, 2024 | 11.41M |
April 01, 2024 | 16.49M |
March 28, 2024 | 16.57M |
March 27, 2024 | 14.50M |
March 26, 2024 | 13.75M |
March 25, 2024 | 15.16M |
March 22, 2024 | 16.57M |
March 21, 2024 | 15.40M |
March 20, 2024 | 15.16M |
Date | Value |
---|---|
March 19, 2024 | 15.16M |
March 18, 2024 | 14.22M |
March 15, 2024 | 14.69M |
March 14, 2024 | 17.27M |
March 13, 2024 | 19.62M |
March 12, 2024 | 18.68M |
March 11, 2024 | 20.90M |
March 08, 2024 | 22.67M |
March 07, 2024 | 22.90M |
March 06, 2024 | 20.32M |
March 05, 2024 | 22.67M |
March 04, 2024 | 17.11M |
March 01, 2024 | 19.07M |
February 29, 2024 | 21.04M |
February 28, 2024 | 21.48M |
February 27, 2024 | 20.60M |
February 26, 2024 | 16.89M |
February 23, 2024 | 18.41M |
February 22, 2024 | 19.73M |
February 21, 2024 | 17.86M |
February 20, 2024 | 17.98M |
February 16, 2024 | 18.75M |
February 15, 2024 | 19.73M |
February 14, 2024 | 19.51M |
February 13, 2024 | 20.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.29M
Minimum
Nov 10 2022
133.02M
Maximum
Feb 11 2021
3.549M
Average
-1.452M
Median
Jun 30 2021
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 984.38M |
Retractable Technologies Inc | -13.19M |
Xtant Medical Holdings Inc | 131.97M |
Asensus Surgical Inc | 45.03M |
Catheter Precision Inc | 0.9737M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -5.405M |
Revenue (Quarterly) | 1.761M |
Total Expenses (Quarterly) | 7.569M |
EPS Diluted (Quarterly) | -0.13 |
Gross Profit Margin (Quarterly) | 28.68% |
Profit Margin (Quarterly) | -306.9% |
Earnings Yield | -56.76% |
Normalized Earnings Yield | -56.76 |